We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




ResMed Acquires Sleep Apnea Firm

By HospiMedica staff writers
Posted on 08 Mar 2001
Print article
ResMed Inc. (San Diego, CA, USA) has acquired Map Medizin-Technologie GmbH (Munich, Germany) for US$69 million in cash. ResMed develops and markets medical equipment for treating sleep-disordered breathing. Map also develops and markets medical devices for sleep-disordered breathing, with a focus on obstructive sleep apnea.

"Map's strengths in R&D, sales, and marketing complement those of ResMed and will strengthen ResMed's market leadership position in Europe,” said Christopher Roberts, executive vice president of ResMed.

"…We believe that we will now have the resources to make an even stronger contribution with innovative devices for the diagnosis and treatment of sleep-disordered breathing,” said Dr. Stefan Madaus, CEO of Map.



Related Links:
Resmed Inc.
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Endoscopic Suturing System
OverStitch
New
Facet Fixation System
ZYFUSE

Print article

Channels

Surgical Techniques

view channel
Image: The machine learning approach identifies wrong-site surgeries (Photo courtesy of 123RF/Rawpixel)

World's First Machine Learning Model Combats Wrong-Site Surgery

Wrong-site surgery (WSS), classified as a critical "Never Event," represents a significant failure in healthcare that should never occur. However, due to widespread underreporting, the true frequency of... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.